HR586: Vietnam Veterans Liver Fluke Cancer Study Act
119th Congress (2025–2027) · House bill · Sponsor: Rep. LaLota, Nick [R-NY-1]
119th Congress (2025–2027) · House bill · Sponsor: Rep. LaLota, Nick [R-NY-1]
| Item | Detail |
|---|---|
| Roll-call votes | 1 |
| Chamber | House |
| Latest vote | 2025-04-07: Passed |
| Latest action | 2025-04-08: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs. |
| Policy area | Armed Forces and National Security |
| Official record | Congress.gov |
Vietnam Veterans Liver Fluke Cancer Study ActThis bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U. S. residents. The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.
Subjects: Asia, Cancer, Conflicts and wars, Congressional oversight, Government studies and investigations, Health information and medical records, Medical research, Veterans' medical care, Vietnam
Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.
| Date | Chamber | Question | Result | Yea | Nay | Not voting | Record |
|---|---|---|---|---|---|---|---|
| 2025-04-07 | House | 2/3 Yea-And-Nay | Passed | 408 | 0 | 20 | Official tally |
HR586 (Vietnam Veterans Liver Fluke Cancer Study Act) was introduced in the 119th Congress (2025–2027) by Rep. LaLota, Nick [R-NY-1].
On 2025-04-08: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
1 recorded vote in the 119th Congress. The most recent, on 2025-04-07, was "2/3 Yea-And-Nay": Passed.